Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Arvinas, Inc. Transaction History
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group
- $169 Billion
- Q3 2025
A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in Arvinas, Inc. stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 57,500 shares of ARVN stock, worth $607,775. This represents 0.29% of its overall portfolio holdings.
Number of Shares
57,500
Previous 57,500
-0.0%
Holding current value
$607,775
Previous $423 Million
15.76%
% of portfolio
0.29%
Previous 0.27%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
237Shares Held
65.1MCall Options Held
1.23MPut Options Held
372K-
Vanguard Group Inc Valley Forge, PA8.56MShares$90.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$66.2 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA5.58MShares$58.9 Million5.5% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.35MShares$35.4 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.13MShares$22.5 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $562M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...